It is estimated that one in ten people carries a mutation in one or more of the genes that control the development of the central nervous system. These genetic mutations lead to a condition known as scid, a disorder that affects between one and three percent of the world’s population. It has been estimated that 10 to 30 percent of all children with SCID have a genetic mutation.
Scid is a common disorder, affecting an estimated 10 to 30 percent of the worlds population. It is a condition that can be fatal; however, it is treatable with gene therapy. Gene therapy refers to the genetic modification of human cells to correct genetic mutations. As such, it is a relatively new concept, and has only recently been used in humans. The first clinical trials were conducted in 2002 and ended in 2005. The treatment was later approved for use by the FDA in December 2011.
gene therapy is a relatively new concept in the history of medicine. While there have been a few very successful treatments before, gene therapy is the first major application of it. It is a relatively new field that has only recently been applied to humans, but it is already being used to treat various diseases, such as leukemia and muscular dystrophy.
Gene therapy is the process of transferring genetic material from a cell to a patient. It uses a technique called nuclear-transfer to modify the patient’s cells with the genetic material. This allows the patient to have a healthy cell that is capable of producing the genetic material needed to cure that patient’s disease.
For some time now, scientists have been trying to figure out how to transfer a gene to a person in a way that doesn’t involve a needle. The scid gene therapy concept is the same idea but instead of using a needle, it is done using a micro-encapsulated virus called AAV. AAV is a virus that has been genetically engineered with a gene that is capable of producing proteins that can be injected into a person’s body.
Imagine a virus that can be injected into a person’s skin and is capable of carrying a gene for a drug to be injected into the person. This is where the scid gene therapy is headed. It’s basically a way to introduce a gene into a person without the use of needles.
We talked about the idea of scid gene therapy in a previous blog entry. It’s a technique that could be used to treat both Alzheimer’s disease and Parkinson’s disease, as well as being used to treat some cancers. However, as the technology matures, we should be seeing some real applications of it.
scid gene therapy is definitely an area of research that is looking to enter the mainstream. I feel like the potential for it to be used on the condition of a person suffering from Parkinson’s disease is pretty high. A person who has lost control over their movements could be helped to regain control, but since Parkinson’s is a progressive disease, this might have to wait until we get more detailed information on the cause.
Scid gene therapy is still a bit of a controversial area, since the science itself is pretty immature. The first clinical trials were carried out in the 1970s. But today the technologies are so advanced that it’s pretty clear we’re going to see some pretty cool applications in the not so distant future.
So there you have it, a look at some of the latest developments in modern gene therapy.